Get Premium to unlock powerful stock data

6 Stocks Trading Below Peter Lynch Value

Bristol-Myers Squibb tops the list

Author's Avatar
Tiziano Frateschi
Oct 10, 2019
Article's Main Image

Several gurus are focusing on stocks whose Peter Lynch fair values are far above their current prices, according to the GuruFocus All-in-One Screener. As of Thursday, the following companies are trading with wide margins of safety and have had positive performance over the last 12 months.

Bristol-Myers Squibb Company (

BMY, Financial) is trading around $50.83 per share. The Peter Lynch value gives the stock a fair price of $80.04, which suggests it is undervalued with a 36% margin of safety. Over the last three months, the stock has registered a positive performance of 11.29%.

53c420b4d03d2186f378dd2944bc3089.png

The company, which develops and markets pharmaceutical products, has a market cap of $83.15 billion and an enterprise value of $78.94 billion.

The stock is trading with a price-earnings ratio of 13.38, which is higher than 70% of companies in the Drug Manufacturers industry. The stock price is currently 19.76% below its 52-week high and 19.66% above its 52-week low. The price-book ratio is 5.14.

The company's largest guru shareholder is the 

Vanguard Health Care Fund (Trades, Portfolio) with 3.12% of outstanding shares, followed by Dodge & Cox with 3.08% and PRIMECAP Management (Trades, Portfolio) with 1.33%.

Sony Corp. (

SNE, Financial) is trading around $57.87 per share. The Peter Lynch value gives the stock a fair price of $151.77, which suggests it is undervalued with a 62% margin of safety. The stock registered a positive three-month performance of 6.42%.

797db602f940334e88769fa78593ebc5.png

The company has a market cap of $71.20 billion and an enterprise value of $69.93 billion.

The stock is trading with a price-earnings ratio of 9.5, which is higher than 80% of companies in the Computer Hardware industry. The stock price is currently 13.65% below its 52-week high and 26.38% above its 52-week low. The price-book ratio is 2.01.

PRIMECAP Management is the company's largest guru shareholder with 3.27% of outstanding shares, followed by

Jim Simons (Trades, Portfolio)’ Renaissance Technologies with 0.30%, Mario Gabelli (Trades, Portfolio) with 0.30% and Daniel Loeb (Trades, Portfolio) with 0.12%.

Celgene Corp. (

CELG, Financial) is trading around $100 per share. The Peter Lynch value gives the stock a fair price of $182.5, which suggests it is undervalued with a 68% margin of safety. Over the last three months, the stock has risen 6.20%.

c514fd5843411ca24aaa515474f4ba67.png

The biopharmaceutical company has a market cap of $70.61 billion and an enterprise value of $81.08 billion.

The stock is trading with a price-earnings ratio of 13.65, which is higher than 65% of companies in the Drug Manufacturers industry. The stock price is currently 0.79% below its 52-week high and 70.05% above its 52-week low. The price-book ratio is 6.94.

The company's largest guru shareholder is Simons’ firm with 1.26% of outstanding shares, followed by

David Abrams (Trades, Portfolio) with 0.95%, John Paulson (Trades, Portfolio) with 0.47% and Paul Tudor Jones (Trades, Portfolio) with 0.16%.

Applied Materials Inc. (

AMAT, Financial) is trading around $51 per share. The Peter Lynch value gives the stock a fair price of $75, which suggests it is undervalued with a 32% margin of safety. Over the last three months, the stock has registered a positive performance of 16.10%.

9a67875e47f61e42311bc2d9a287a47a.png

The provider of semiconductor manufacturing equipment has a market cap of $47.41 billion and an enterprise value of $48.71 billion.

The stock is trading with a price-earnings ratio of 17.17, which is higher than 57% of companies in the Semiconductors industry. The stock price is currently 3.38% below its 52-week high and 76.59% above its 52-week low. The price-book ratio is 5.87.

Chris Davis (Trades, Portfolio) is the company's largest guru shareholder with 1.70% of outstanding shares, followed by the  Parnassus Endeavor Fund (Trades, Portfolio) with 0.72% and PRIMECAP Management with 0.54%.

Lam Research Corp. (

LRCX, Financial) is trading around $236 per share. The Peter Lynch value gives the stock a fair price of $343, which suggests it is undervalued with a 32% margin of safety. Over the last three months, the stock has risen 27.97%.

69c11d9a1539c8a72d9df3cf5517d555.png

The company, which provides equipment for fabricating semiconductors, has a market cap of $33.77 billion and an enterprise value of $32.82 billion.

The stock is trading with a price-earnings ratio of 17, which is higher than 56% of companies in the Semiconductors industry. The stock price is currently 4.84% below its 52-week high and 90.09% above its 52-week low. The price-book ratio is 7.53.

The company's largest guru shareholder is the Parnassus Endeavor Fund with 0.71% of outstanding shares, followed by Pioneer Investments (Trades, Portfolio) with 0.70%, Simons’ firm with 0.33% and

Joel Greenblatt (Trades, Portfolio) with 0.12%.

NXP Semiconductors NV (

NXPI, Financial) is trading around $106 per share. The Peter Lynch value gives the stock a fair price of $156.66, which suggests it is undervalued with a 32% margin of safety. Over the last three months, the stock has registered a positive performance of 10.86%.

8b57e9a65b4d9727bc54906c775ed617.png

The semiconductor company has a market cap of $29.54 billion and an enterprise value of $35.24 billion.

The stock is trading with a price-earnings ratio of 16.06, which is higher than 58% of companies in the Semiconductors industry. The stock price is currently 6.64% below its 52-week high and 56.70% above its 52-week low. The price-book ratio is 3.34.

Steven Cohen (Trades, Portfolio) is the company's largest guru shareholder with 0.99% of outstanding shares, followed by Larry Robbins (Trades, Portfolio) with 0.86% and Pioneer Investments with 0.55%.

Disclosure: I do not own any shares of any stocks mentioned in this article.

Read more here:

Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.

Also check out:
Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.
Rating:
0 / 5 (0 votes)

Please Login to leave a comment